Abrysvo act-o-vials
Ended Awarded Last action
- Contract number
- SPE2DR26FAKCL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,925
Award facts
- Contract value 100% obligated
- $19,924.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,924.80 by the Defense Logistics Agency on December 15, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order for Act-O-Vials represents a competitive award with no set-aside designation and will be performed at the contractor's Conshohocken facility. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a substantial value of $999,999,999.00 and extends through December 2026.
The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This prime contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for Act-O-Vials represents one of numerous small-value transactions fulfilling federal medical supply needs through this flexible contract mechanism, demonstrating the contractor's capability to meet Defense Logistics Agency procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26FAKCL?
SPE2DR26FAKCL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FAKCL worth?
The government has obligated $19,925 on SPE2DR26FAKCL.
Is contract SPE2DR26FAKCL an order under another contract?
Yes. SPE2DR26FAKCL is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKCL competed?
The extent of competition for SPE2DR26FAKCL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award